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INTRODUCTION

I
t is well known that pharmacotherapy for the treatment of glaucoma lowers intraocular pressure and delays disease progression [1] . Likewise and confounding, patient compliance with medications remains limited, with the literature suggesting rates of 70% or less [2] [3] . Multiple reasons have been explored, including some related to the bottle itself [4] [5] . Recently, two articles have highlighted potential issues when relying on the systematically color labeled bottle caps to differentiate and communicate about medications. Marando et al [6] surveyed glaucoma patients at a tertiary care office and found that 65% utilized bottle cap color to differentiate between medications, significantly more than medication name itself (19%). A concurrent study by Dave et al [7] found that a sampling of 100 patients used 102 unique descriptions for the colors of 11 bottle caps. Three physicians independently attempted to identify the medications based on the patient description, and among individual patients the mean number of medications demonstrating agreement was only 6 of 11 (55%). Collectively, these data raise concern for utilizing bottle cap color to identify and discuss ophthalmic medications, particularly in glaucoma patients prone to impaired visual acuity, contrast sensitivity and color vision [8] . This study was designed to determine how frequently patients were able to correctly identify the bottle cap color of ten commonly used ophthalmic medications in each eye independently and correlate this information with visual acuity, automated visual field and clinical testing of color vision.
SUBJECTS AND METHODS Ethical Approval
The study was performed according to the Declaration of Helsinki, with approval from the Institutional Review Board at the University of Kentucky. Informed consent was obtained for all patients. Patients were prospectively recruited to participate in the study from the glaucoma clinics at the University of Kentucky between June 2014 and September 2016. Inclusion criteria included: age 18 years or greater, diagnosis of glaucoma on stable topical medication regimen, self-administered eyedrops, measurable Snellen visual acuity, Humphrey Visual Field (HVF) testing within 6mo of enrollment, familiarity with the 10 test colors and willingness to participate. Patients with hereditary or acquired color vision deficiencies were excluded. Snellen visual acuity was tested in a standard 6 foot exam room. HVF testing was performed using the 24-2 SITA FAST algorithm (Carl Zeiss Meditec Inc., Dublin, CA, USA). Color 170 vision was assessed for each eye using standard Ishihara color plates. Each eye was also tested independently for the ability to correctly identify the bottle cap color of ten commonly used ophthalmic medications presented against a white background in a standardized fashion and sequence. Cap colors included yellow, purple, orange, blue, green, red, teal, pink, gray and tan.
Statistical analysis was conducted on the data using JMP 12.2 Pro (SAS Institute Inc., Cary, NC, USA) to correlate these results with the most recent measurements of visual acuity (Snellen visual acuity converted to logMAR) [9] and glaucoma severity (visual field mean deviation using a t ratio test 
DISCUSSION
In 1983, the American Academy of Ophthalmology successfully advocated to the US Food and Drug Administration to enter an informal and voluntary agreement with pharmaceutical companies to create a uniform color for bottle caps of different classes of medications, which has largely been in practice ever since [10] . As a result, recognition of bottle cap color has become a common method for patients to distinguish medications and for providers and patients to discuss medication use and compliance [5] . This study attempted to measure the effect of glaucoma on discrimination of these colored caps and found that patients were less likely to correctly identify the color of caps as visual acuity and visual field mean deviation worsened.
Multiple linear regression analysis suggested that the visual field effect may be more related to visual acuity, and decreased bottle cap color recognition could not be independently attributed to this marker of glaucoma severity.
A recent study highlighted the concerns when relying upon bottle cap color for communication of medications, with poor agreement between patients and physicians when describing 11 distinct medication bottle caps [6] . 
Identification of bottle cap color in ophthalmic medications
